TherapeuticsMD (TXMD) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1.99 High: 2.16

52 Week Range

Low: 0.84 High: 2.94

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Market capMarket cap information

    $23 Mln

  • Revenue (TTM)Revenue (TTM) information

    $3 Mln

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    0 %

  • ROCEROCE information

    -- %

  • P/E RatioP/E Ratio information

    199

  • P/B RatioP/B Ratio information

    0.9

  • Industry P/EIndustry P/E information

    24.51

  • EV/EBITDAEV/EBITDA information

    14.8

  • Div. YieldDiv. Yield information

    0 %

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $0

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    11,574,362

10 Years Aggregate

CFO

$-896.75 Mln

EBITDA

$-853.70 Mln

Net Profit

$-951.33 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
TherapeuticsMD (TXMD)
22.7 -11.5 22.7 116.2 -18.9 -50.5 -39.8
BSE Sensex*
-14.8 -11.3 -15.4 -5.2 6.9 7.6 11.1
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 01-Apr-2026  |  *As on 02-Apr-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2021
2020
2019
TherapeuticsMD (TXMD)
89.5 -61.5 -59.7 -70.2 -50.0 -36.5
S&P Small-Cap 600
4.0 7.0 13.9 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
TherapeuticsMD (TXMD)
2.0 23.0 2.8 0.3 -75.9 1.1 199 0.9
9.1 2,179.2 510.2 146.9 37.2 35.6 15.5 4.6
12.7 3,812.0 3,018.8 72.1 12.6 -80 54.3 86.1
171.8 8,210.1 638.5 -183.2 -27.4 -252.1 -- 92.9
74.5 13,446.3 502.1 -729.3 -125.8 41.2 -- 123.7
42.0 4,055.0 761.4 99.7 7.3 15 46.5 5.7
13.5 11,237.7 345,831.0 56,586.0 21.5 15.8 18.7 2.9
23.1 11,653.6 4,715.0 -232.0 0.9 -3.7 -- 1.8
8.3 7,645.3 7,227.1 386.1 16.6 6.9 13.8 0.9
199.6 3,841.5 268.1 124.5 60.0 13.5 31.5 4.0

Shareholding Pattern

View Details
loading...

About TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD...  and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Address: 951 Yamato Road, Boca Raton, FL, United States, 33431  Read more

  • Executive Chairman

    Governor Thomas G. Thompson

  • Executive Chairman

    Governor Thomas G. Thompson

  • Headquarters

    Boca Raton, FL

  • Website

    https://www.therapeuticsmd.com

Edit peer-selector-edit
loading...
loading...

FAQs for TherapeuticsMD (TXMD)

The share price of TherapeuticsMD Inc (TXMD) is $2.00 (NASDAQ) as of 01-Apr-2026 16:26 EDT. TherapeuticsMD Inc (TXMD) has given a return of -18.9% in the last 3 years.

The P/E ratio of TherapeuticsMD Inc (TXMD) is 199.00 times as on 31-Mar-2026, a 712 premium to its peers’ median range of 24.51 times.
The P/B ratio of TherapeuticsMD Inc (TXMD) is 0.89 times as on 31-Mar-2026, a 84 discount to its peers’ median range of 5.66 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2024
-4.55
0.36
2023
-2.52
0.89
2022
0.85
2.70
2021
-0.02
-0.03
2020
-0.04
-0.06

The 52-week high and low of TherapeuticsMD Inc (TXMD) are Rs 2.94 and Rs 0.84 as of 02-Apr-2026.

TherapeuticsMD Inc (TXMD) has a market capitalisation of $ 23 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.

Before investing in TherapeuticsMD Inc (TXMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.